Research Grants 18 show all


$1.3M
2010

$3.6M
2011

$1.6M
2012

$1.3M
2019

$997.4K
2020

Patents 149show all

  • 46
    A61K - Preparations for medical, dental, or toilet purposes
  • 25
    A61L - Methods or apparatus for sterilising materials or objects in general
  • 14
    A61Q - Specific use of cosmetics or similar toilet preparations
  • 12
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 6
    C07F - Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
  • 6
    C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients
  • 6
    C09D - Coating compositions, e.g. paints, varnishes or lacquers
  • 5
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 5
    G01S - Radio direction-finding
  • 3
    A01N - Preservation of bodies of humans or animals or plants or parts thereof

Clinical Trials 20show all

9Phase 15Phase 25Phase 31Phase 1/Phase 2

SEC Filings show all


46
8-K

11
10-Q

6
D

4
10-K

1
S-1

Contact Information

Swampscott, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2015-03-30$50,000,008$50,000,008Equity
2014-03-10$3,502,125$3,502,125Debt
2013-02-28$11,000,000$11,000,000Equity
2011-09-29$5,999,989$5,999,968Equity, Option to Acquire
2009-07-02$2,000,000$2,000,000Equity

Key Executives

  • Nathan Stasko
    Executive Officer, Director
  • Mark Schoenfisch
    Executive Officer, Director
  • F. Neal Hunter
    Director
  • F Neal Hunter
    Director
  • Robert A Ingram
    Director
  • John W Palmour
    Director
  • W Kent Geer
    Director
  • G Kelly Martin
    Director
  • Sean Murphy
    Director